Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer

Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer. The drugmaker, which has been fighting talc-related lawsuits for more than a decade, said that the settlement is conditioned on at least 95% of remaining claimants participating. A U.S. bank

Johnson & Johnson has agreed to pay US$5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer.

Johnson & Johnson reached a potential $5.5 billion settlement on Monday in an effort to settle past legal woes over claims that its talc products were behind cases of ovarian cancer.  The settlement would cover roughly 76,000 claims with no cap on payouts.  Johnson & Johnson said it plans to issue the first round of…

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight  Toronto Star

Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer

Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight  AP News

Johnson & Johnson ​said on Monday it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and ‌other talc products cause ovarian cancer, in a landmark deal that could end a contentious legal battle that has dogged the company for a decade.

The proposed settlement aims to end a long-standing legal battle that has weighed on the New Jersey-based firm for years.

Johnson & Johnson said Monday that has reached a proposed $5.5 billion settlement to resolve most remaining talcum-based baby powder lawsuits.

Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming its baby powder and other talcum powder products caused ovarian cancer, the company says.

Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle Johnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby ⁠powder and other talc products caused ⁠ovarian cancer, in a landmark ​deal that could end a contentious, decade

NEW YORK, July 27 (Reuters) - Johnson & Johnson JNJ.N said on Monday it would pay $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for yea

Johnson & Johnson said it would pay $5.5 billion to resolve tens of ⁠thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.

The deal must be accepted by 95% of the ovarian cancer claimants in state or federal court before it becomes final

The settlement covers claims alleging that J&J's talc products cause ovarian cancer.

NEW YORK: Johnson & Johnson said on Monday (Jul 27) it would pay US$5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.J&J said the

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits  Reuters